IRIS

Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study / Findling, James W; Fleseriu, Maria; Newell Price, John; Petersenn, Stephan; Pivonello, Rosario; Kandra, Albert; Pedroncelli, Alberto M.; Biller, Beverly M. K.. - In: ENDOCRINE. - ISSN 1355-008X. - (2016), pp. 1-8. [10.1007/s12020-016-0978-6]

Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

PIVONELLO, ROSARIO;
2016
2016
ENDOCRINE
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study / Findling, James W; Fleseriu, Maria; Newell Price, John; Petersenn, Stephan; Pivonello, Rosario; Kandra, Albert; Pedroncelli, Alberto M.; Biller, Beverly M. K.. - In: ENDOCRINE. - ISSN 1355-008X. - (2016), pp. 1-8. [10.1007/s12020-016-0978-6]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/646645
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact